| Age | Years | |
| Median | 52.5 | |
| Range | 31 - 87 | |
| ER/PR | n (%) | |
| Positive | 28 (70) | |
| Negative | 12 (30) | |
| HER-2 | ||
| Positive | 5 (12.5) | |
| Negative | 35 (87.5) | |
| Metronomic QT | ||
| CTX + MTX | 27 (67.5) | |
| CTX + Capecitabine | 10 (25) | |
| Capecitabine | 3 (7.5) |